Oric Pharmaceuticals Inc. Insider Trading

ORIC

Last 12 months

Insiders sold $2.96M and bought nothing on the open market.

83% of the selling was scheduled in advance under 10b5-1 plans. Chief Financial Officer Dominic Piscitelli sold 97K on Dec 16, 2025, 14% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2025.

Net open-market

−$2.96M

0 buys · 12 sales

Under a 10b5-1 plan

83%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Jun 2025

Jun 23, 2025

Get an email when ORIC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 20	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	14,000	$13.53	189K	17%	Form 4
Oct 1	Richard A. Heyman Director	Sold10b5-1 plan 2 parts	6,700	$12.91 average	87K	2.7%	Form 4
Sep 28	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	13,400	$13.53	181K	16%	Form 4
Sep 24	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan 2 parts	600	$13.51 average	8K	0.9%	Form 4
Aug 26	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	77,000	$13.69	$1.05M	52%	Form 4
Jul 24	Richard A. Heyman Director	Sold10b5-1 plan 2 parts	13,100	$12.02 average	157K	5.1%	Form 4
Jul 6	Richard A. Heyman Director	Sold10b5-1 plan	300	$12.00	4K	0.1%	Form 4
Feb 24	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	52,000	$13.51	703K	43%	Form 4
Jan 16	Richard A. Heyman Director	Sold10b5-1 plan 2 parts	6,700	$12.00 average	80K	2.6%	Form 4
Dec 16, 2025	Dominic Piscitelli Chief Financial Officer	SoldNo plan	10,720	$9.06	97K	14%	Form 4
Dec 16, 2025	Jacob Chacko President and CEO	SoldNo plan	33,374	$9.06	302K	5.4%	Form 4
Dec 16, 2025	Pratik S Multani Chief Medical Officer	SoldNo plan	10,720	$9.06	97K	14%	Form 4
Oct 6, 2025	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	11,000	$14.52	160K	19%	Form 4
Oct 6, 2025	Jacob Chacko President and CEO	Sold10b5-1 plan	37,461	$12.32	462K	6.6%	Form 4
Sep 30, 2025 – Oct 1, 2025	Jacob Chacko President and CEO	Sold10b5-1 plan 2 parts	87,539	$12.03 average	$1.05M	13%	Form 4
Sep 22, 2025	Jacob Chacko President and CEO	Sold10b5-1 plan	125,000	$10.80	$1.35M	16%	Form 4
Jul 1, 2025	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	20,000	$10.05	201K	29%	Form 4
Jun 23, 2025 – Jun 24, 2025	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan 3 parts	33,500	$10.48 average	351K	33%	Form 4
Jun 20, 2025 – Jun 23, 2025	Angie You Director	Bought 2 parts	28,000	$9.39 average	263K	New	Form 4
Jun 12, 2025	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan	300	$10.00	3K	0.3%	Form 4
Jun 10, 2025 – Jun 11, 2025	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan 3 parts	3,300	$10.01 average	33K	3.1%	Form 4
Jun 6, 2025 – Jun 9, 2025	Dominic Piscitelli Chief Financial Officer	Sold10b5-1 plan 2 parts	2,900	$10.01 average	29K	2.7%	Form 4
Dec 16, 2024	Dominic Piscitelli Chief Financial Officer	SoldNo plan	8,851	$8.28	73K	7.7%	Form 4
Dec 16, 2024	Pratik S Multani Chief Medical Officer	SoldNo plan	8,850	$8.28	73K	16%	Form 4
Dec 16, 2024	Jacob Chacko President and CEO	SoldNo plan	24,660	$8.28	204K	3.1%	Form 4

Oct 2010b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 14,000 at $13.53
189K
17% of stake
Oct 110b5-1 plan
Richard A. Heyman
Director · sold 6,700 at avg $12.91
87K
2.7% of stake
Sep 2810b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 13,400 at $13.53
181K
16% of stake
Sep 2410b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 600 at avg $13.51
8K
0.9% of stake
Aug 2610b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 77,000 at $13.69
$1.05M
52% of stake
Jul 2410b5-1 plan
Richard A. Heyman
Director · sold 13,100 at avg $12.02
157K
5.1% of stake
Jul 610b5-1 plan
Richard A. Heyman
Director · sold 300 at $12.00
4K
0.1% of stake
Feb 2410b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 52,000 at $13.51
703K
43% of stake
Jan 1610b5-1 plan
Richard A. Heyman
Director · sold 6,700 at avg $12.00
80K
2.6% of stake
Dec 16, 2025No plan
Dominic Piscitelli
Chief Financial Officer · sold 10,720 at $9.06
97K
14% of stake
Dec 16, 2025No plan
Jacob Chacko
President and CEO · sold 33,374 at $9.06
302K
5.4% of stake
Dec 16, 2025No plan
Pratik S Multani
Chief Medical Officer · sold 10,720 at $9.06
97K
14% of stake
Oct 6, 202510b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 11,000 at $14.52
160K
19% of stake
Oct 6, 202510b5-1 plan
Jacob Chacko
President and CEO · sold 37,461 at $12.32
462K
6.6% of stake
Sep 30, 2025 – Oct 1, 202510b5-1 plan
Jacob Chacko
President and CEO · sold 87,539 at avg $12.03
$1.05M
13% of stake
Sep 22, 202510b5-1 plan
Jacob Chacko
President and CEO · sold 125,000 at $10.80
$1.35M
16% of stake
Jul 1, 202510b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 20,000 at $10.05
201K
29% of stake
Jun 23, 2025 – Jun 24, 202510b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 33,500 at avg $10.48
351K
33% of stake
Jun 20, 2025 – Jun 23, 2025
Angie You
Director · bought 28,000 at avg $9.39
263K
New position
Jun 12, 202510b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 300 at $10.00
3K
0.3% of stake
Jun 10, 2025 – Jun 11, 202510b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 3,300 at avg $10.01
33K
3.1% of stake
Jun 6, 2025 – Jun 9, 202510b5-1 plan
Dominic Piscitelli
Chief Financial Officer · sold 2,900 at avg $10.01
29K
2.7% of stake
Dec 16, 2024No plan
Dominic Piscitelli
Chief Financial Officer · sold 8,851 at $8.28
73K
7.7% of stake
Dec 16, 2024No plan
Pratik S Multani
Chief Medical Officer · sold 8,850 at $8.28
73K
16% of stake
Dec 16, 2024No plan
Jacob Chacko
President and CEO · sold 24,660 at $8.28
204K
3.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ORIC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ORIC

CompareIntrinsic value

DSGNDesign Therapeutics, Inc.

$10.63+2.80%10

TENXTenax Therapeutics Inc.

$1.81-1.63%10

LEXXLexaria Bioscience Corp.

$4.07+0.99%10

PRPHProPhase Labs Inc.

$0.01-42.00%0

CBIOCrescent Biopharma, Inc.

$13.42+2.76%50

OGNOrganon & Co.

$13.83-0.14%28

PTCTPTC Therapeutics, Inc.

$68.97+1.25%65

BCYCBicycle Therapeutics PLC

$3.72+1.36%40

Held by ETFs

ORIC is in 36 US ETFs. The largest of them, with ORIC's weight in each:

Spot a number that looks wrong? Check it in ORIC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ORIC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.